Task: Answer the multiple choice question.
Question: Which compound exhibits a -16.874% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. COc1ccc(N(CC(=O)NC2CCCC2)C(=O)Cn2nnc(-c3ccc(OC)c(OC)c3)n2)c(OC)c1
b. Nc1c(C(=O)NCc2ccco2)sc2nc3c(cc12)C(=O)CCC3
Answer: b. Nc1c(C(=O)NCc2ccco2)sc2nc3c(cc12)C(=O)CCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1c(C(=O)NCc2ccco2)sc2nc3c(cc12)C(=O)CCC3
Nc1c(C(=O)NCc2ccco2)sc2nc3c(cc12)C(=O)CCC3
3-amino-N-(furan-2-ylmethyl)-5-oxo-7,8-dihydro-6H-thieno[2,3-b]quinoline-2-carboxamide